ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 28 of 58
Up
JMBS 2020, 5(6): 195–201
https://doi.org/10.26693/jmbs05.06.195
Clinical Medicine

Markers of Endothelial Dysfunction as Predictors of Complicated Acute Myocardial Infarction in Combination with Type 2 Diabetes Mellitus

Feldman D. А., Ryndina N. G., Kravchun P. G.
Abstract

Today, the endothelium is considered to be a multifunctional organ and a non-specific marker in the pathogenesis of diseases of the cardiovascular system. The course of diseases of the cardiovascular system depends on the presence of comorbid pathology, where type 2 diabetes is one of the possible representations of such pathology. The purpose of the study was to determine the diagnostic role of marker of endothelial dysfunction in patients with acute myocardial infarction with concomitant type 2 diabetes mellitus with regard to the clinical course of comorbid conditions. Material and methods. The study design consisted of 120 patients. They were divided into 2 groups: Group 1 consisted of patients with acute myocardial infarction and concomitant type 2 diabetes (n=69), Group 2 consisted of patients with acute myocardial infarction without concomitant type 2 diabetes (n=51). Patients of both groups matched on age and sex (60 men (50%) and 60 women (50%); their average age was 66.35±0.91 years, р<0,05). The control group consisted of 20 almost healthy people, among them 12 women (60%) and 8 men (40%) (average age was equal to 45.17±2.88 years). Examination of patients was conducted on the basis of Municipal Non-profit Enterprise "City Clinical Hospital No. 27" of Kharkiv City Council in the department of cardiology for patients with acute myocardial infarction. Diagnoses were determined according to the current criteria. All patients enrolled in the study signed a voluntary informed consent to participate in it. All patients underwent general clinical and instrumental examinations. The level of endothelial monocyte-activating polypeptide II in participants of the study was determined on the first day of acute myocardial infarction by using a commercial test system "Human Endothelial monocyte activating polepeptide II ELISA KIT". Results and discussion. According to the results of the study, in patients with acute myocardial infarction in combination with type 2 diabetes the levels of endothelial monocyte-activating polypeptide II was higher than in patients without concomitant type 2 diabetes by 1.65 times (p <0.05). The course of the study revealed the level of endothelial monocyte-activating polypeptide II, which was marked by high risk of cardiogenic shock and acute left ventricular failure. Having analyzed the parameter of endothelial dysfunction in terms of mortality, the researchers made the following conclusion: the endothelial monocyte-activating polypeptide II values greater than 3.44 ng/ml were the predictor of cardiovascular death probability during 6 months. Conclusion. The results of analysis of endothelial function made with use of the marker of endothelial monocyte-activating polypeptide II in patients with acute myocardial infarction with concomitant type 2 diabetes showed that such indicator can be deemed as predictor in complicated comorbid conditions

Keywords: markers of endothelial dysfunction, acute myocardial infarction, type 2 diabetes mellitus

Full text: PDF (Ukr) 297K

References
  1. Stepanova TV, Ivanov AN, Popykhova EB, Lagutina DD. Molekulyarnye markery endotelialnoy disfunktsii [Molecular markers of endothelial dysfunction]. Sovremennye problemy nauki i obrazovaniya. 2019; 1. [Russian]. Available from: https://www.science-education.ru/ru/article/view?id=28530
  2. Orlova YaA, Ageev FT. Zhestkost arteriy kak integralnyy pokazatel serdechno-sosudistogo riska: fiziologiya, metody otsenki i medikamentoznoy korrektsii [Arterial stiffness as an integral indicator of cardiovascular risk: physiology, methods of assessment and drug correction]. Serdtse. 2006; 2(5): 65-69. [Russian]
  3. Bulas J, Potočárová M, Filková M, Simková A, Murín J. Impact of aortic stiffness on central hemodynamics and cardiovascular system. Vnitrni Lekarstvi. 2013; 59(6): 444-449.
  4. Baumann M, Wassertheurer S, Suttmann Y, Burkhardt K, Heemann U. Aortic pulse wave velocity predicts mortality in chronic kidney disease stages 2-4. Journal of Hypertension. 2014; 32: 899-903.
  5. Boutouyrie P, Tropeano AI, Asmar R. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients. Hypertension. 2002; 39(1): 10-15. https://doi.org/10.1161/hy0102.099031
  6. Crichton GE, Elias MF, Robbins MA. Cardiovascular health and arterial stiffness: the Maine-Syracuse Longitudinal Study. Journal of Human Hypertension. 2014; 28(7): 444-449. https://doi.org/10.1038/jhh.2013.131
  7. Dijk JM, Algra A, Graaf Y. Carotid stiffness and the risk of new vascular events in patients with manifest cardiovascular disease. The SMART study. European Heart Journal. 2005; 26: 1213-1220. https://doi.org/10.1093/eurheartj/ehi254
  8. Kato A, Takita T, Furuhashi M, Maruyama Y, Miyajima H, Kumagai H. Brachial-ankle pulse wave velocity and the cardio-ankle vascular index as a predictor of cardiovascular outcomes in patients on regular hemodialysis. Therapeutic Apheresis and Dialysis. 2012; 16(3): 232-241. https://doi.org/10.1111/j.1744-9987.2012.01058.x
  9. Lim HE, Park CG, Shin SH. Aortic pulse wave velocity as an independent marker of coronary artery diseases. Blood Press. 2004; 13(6): 369-375. https://doi.org/10.1080/08037050410004800
  10. Mitchell GF, Hwang Sh-J, Vasan RS. Arterial stiffness and cardiovascular events: The Framingham Heart Study. Circulation. 2010; 121(4): 505-11. https://doi.org/10.1161/CIRCULATIONAHA.109.886655
  11. Mitchell GF, Guo CY, Benjamin EJ, Larson MG, Keyes MJ, Vita JA. Cross-sectional correlates of increased aortic stiffness in the community: the Framingham heart study. Circulation. 2007; 13: 2628-2636. https://doi.org/10.1161/CIRCULATIONAHA.106.667733
  12. Satoh-Asahara N, Kotani K, Yamakage H, Yamada T, Araki R, Okajima T. Cardio-ankle vascular index predicts for the incidence of cardiovascular events in obese patients: A multicenter prospective cohort study (Japan Obesity and Metabolic Syndrome Study: JOMS). Atherosclerosis. 2015; 242: 461-468. https://doi.org/10.1016/j.atherosclerosis.2015.08.003
  13. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. Journal of the American College of Cardiology. 2010; 55(13): 1318-1327. https://doi.org/10.1016/j.jacc.2009.10.061
  14. Handzyuk VA. Analiz zakhvoryuvanosti na ishemichnu khvorobu sertsya v Ukraini [Analysis of the incidence of coronary heart disease in Ukraine]. Ukrainskyi kardiolohichnyi zhurnal. 2014; 3: 45-52. [Ukrainian]
  15. Kovalenko VM, Kornatskyi VM. Problemy zdorov’ya i medychnoi dopomohy ta model pokrashchennya v suchasnykh umovakh (posibnyk) [Health and medical problems and the model of improvement in modern conditions (manual)]. K; 2016. 261 s. [Ukrainian]
  16. Kravchuk NH, Rudenko NH. Pokaznyky zdorov’ya naselennya ta vykorystannya resursiv okhorony zdorov’ya v Ukraini za 2013-2014 roky [Indicators of population health and use of health resources in Ukraine for 2013-2014]. Analitychno-statystychnyi dovidnyk. K; 2015. 325 s. [Ukrainian]
  17. Zaklady okhorony zdorov’ya ta zakhvoryuvanist naselennya Ukrainy u 2013 rotsi. Derzhavna sluzhba statystyky Ukrainy. Statystychnyi byuleten [Health care facilities and morbidity of the population of Ukraine in 2013. State Statistics Service of Ukraine. Statistical bulletin]. K; 2014. [Ukrainian]. Available from: www.ukrstat.gov.ua
  18. Sakharnyi diabet [Diabetes mellitus]. Informatsionnyi byulleten. 2013; 312. [Russian]. Available from: http://www.who.int/ru/
  19. Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, et al. Guideline on diabetes, pre-diabetes, and cardiovascular diseases, executive summary. Europ Heart J. 2007; 28: 88-136. https://doi.org/10.1016/S1885-5857(07)60205-9
  20. Shindler DM, Palmeri ST, Antonelli TA, Sleeper LA, Boland J, Cocke TP, et al. Diabetes mellitus in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK trial registry. J Am Coll Cardiol. 2000; 36 (3): 1097-1103. https://doi.org/10.1016/S0735-1097(00)00877-9
  21. Zeymer U. Diabetes as coronary artery disease equivalent revisited. Results of the prospective REACH-registry. European Heart Journal. 2011; 32: 65.
  22. Rajendran P, Rengarajan T, Thangavel J, Nishigaki Y, Sakthisekaran D, Sethi G, et al. The vascular endothelium and human disease. Int J Biol Sci. 2013; 9(10): 1057-1069. https://doi.org/10.7150/ijbs.7502
  23. Berezin AE, Kruzlyak P. Tsirkuliruyushchie endotelialnye apopticheskie mikrochastitsy kak novyy marker kardiovaskulyarnogo riska (obzor literatury) [Circulating endothelial apoptotic microparticles as a new marker of cardiovascular risk (literature review)]. Ukrayinskiy medichniy chasopis. 2014; 5(103): 83-88. [Russian]
  24. Mogilnitskaya LA, Mankovskiy BN. Soderzhanie endotelialnogo monotsitaktiviruyushchego peptida-II u bolnykh sakharnym diabetom 1 tipa s mikroangiopatiyami i arterialnoy gipertenziey [The content of endothelial monocyte-activating peptide-II in patients with type 1 diabetes mellitus with microangiopathies and arterial hypertension]. Mezhdunarodnyy zhurnal «Sakharnyy diabet». 2016; 19(4): 309-314. [Russian] https://doi.org/10.14341/DM7674
  25. Mogilnitskaya LA, Mankovskiy BN. Povyshenie urovnya endotelialnogo monotsitaktiviruyushchego peptida-II v syvorotke krovi bolnykh arterialnoy gipertenziey v sochetanii s sakharnym diabetom 2-ogo tipa i ozhireniem [Increase in the level of endothelial monocyte-activating peptide-II in the blood serum of patients with arterial hypertension in combination with type 2 diabetes mellitus and obesity]. Mezhdunarodnyy zhurnal «Ozhirenie i metabolizm». 2016; 13(3): 49-53. [Russian] https://doi.org/10.14341/omet2016349-53
  26. Teregulov YuE, Khusainova DK, Mukhametshina FN, Abdulganieva DI, Mangusheva MM. Rol zhyostkosti arterialnoy sistemy i pokazateley gemodinamiki v otsenke endotelialnoy funktsii [The role of arterial stiffness and hemodynamic parameters in the assessment of endothelial function]. Vestnik sovremennoy klinicheskoy meditsiny. 2014; 7(1): 17-21. [Russian]